Business
Fourth dose cohort initiated in CHM 1101 Phase 1 trial
Fourth dose cohort initiated in CHM 1101 Phase 1 trial
About this update from Chimeric Therapeutics Limited
[{"type":"text","content":"Chimeric Therapeutics Ltd has released a press release. View Attachment","length":249,"tagName":"div"}]